What is the first gene therapy approved for inherited hearing loss?

The first gene therapy approved for inherited hearing loss is Otarmeni, developed by Regeneron.

Who will receive the new gene therapy for hearing loss for free?

Regeneron will provide the groundbreaking gene therapy for inherited hearing loss free to patients in the United States.

What is the success rate of the new gene therapy for hearing loss?

In clinical trials, the gene therapy significantly improved hearing in a majority of participating children, with some experiencing essentially normal hearing restoration.

Home / Health / First Gene Therapy for Childhood Hearing Loss Approved

First Gene Therapy for Childhood Hearing Loss Approved

24 Apr

•

Summary

FDA approved the first gene therapy for inherited hearing loss.
The one-time treatment is for a rare condition affecting up to 50 US babies annually.
Regeneron will provide the groundbreaking therapy free to US patients.

First Gene Therapy for Childhood Hearing Loss Approved

The US Food and Drug Administration has granted approval for the first-ever gene therapy designed to treat inherited hearing loss. This innovative, one-time treatment targets a rare genetic condition that impacts up to approximately 50 infants born annually in the United States. In clinical trials, the therapy demonstrated remarkable efficacy, significantly improving hearing in a majority of participating children.

Developed by biotechnology firm Regeneron, the therapy, named Otarmeni, is administered via a surgical procedure. The company has committed to providing this life-changing treatment free of charge to patients within the US. This move aims to set a precedent for making advanced biotech innovations accessible to those in need, embodying the potential of scientific advancement to offer profound gifts.